CompletedNCT00304681
Concerta or immediate-release methylphenidate for after-school ADHD symptoms
About this title
Read the official source — NCT00304681Medication studyAges 6–12
Understand this study
Who was this study for?
Listed age limits: 6 years to 12 years.
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- 147
- Sponsor
- Janssen-Ortho Inc., Canada
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Not clearly listed
- Age range
- From 6 Years to 12 Years
- Official registry ID
- NCT00304681
- Official title
Show the full official title
The Effectiveness of CONCERTA® vs. Usual Clinical Care With Immediate Release Methylphenidate (IR MPH) in Children (6-12 Years) With Attention Deficit Hyperactivity Disorder (ADHD): A Randomized, Open-Label Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedLocations not listed
Questions about this study
Who is behind this study?
The study sponsor is Janssen-Ortho Inc., Canada.
Did this study involve medication?
Yes. The study involved medication, including OROS*-Methylphenidate.
Who was this study for?
Listed age limits: 6 years to 12 years.
